Register to leave comments

  • News bot Aug. 13, 2026, 9:03 p.m.

    📋 ATRIUM THERAPEUTICS, INC. (RNA) - Financial Results

    Filing Date: 2026-08-13

    Accepted: 2026-08-13 16:50:28

    Event Type: Financial Results

    Event Details:

    ATRIUM THERAPEUTICS, INC. (RNA) Reports the reporting period Financial Results ATRIUM THERAPEUTICS, INC. (RNA) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 33653
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 72334

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Loss From Operations 12.86K 39.90K $-27.03K -67.76%
    Other Income Expense Interest Income 2.10K 2.76K $-653.00 -23.69%
    Other Income Expense Total Other Income Expense 15.00 322.00 $-307.00 -95.34%
    Total Other Income Expense 15.00 3.08K $-3.06K -99.51%
    Net Loss 12.88K 36.82K $-23.94K -65.02%
    Property Equipment Net 4.07K 2.72K $1.34K +49.27%
    Current Liabilities Accounts Payable 3.51K 4.40K $-885.00 -20.12%
    Current Liabilities Accrued Liabilities 13.31K 8.95K $4.37K +48.82%
    Other Long Term Liabilities 775.00 574.00 $201.00 +35.02%
    Revenue 3.00K 3.85K $-843.00 -21.91%
    Loss from Operations 22.62K 12.86K $9.75K +75.82%
    Net Loss 20.19K 12.88K $7.31K +56.74%
    Property and Equipment, Net 4.07K 2.72K $1.34K +49.27%
    Accounts Payable 3.51K 4.40K $-885.00 -20.12%
    Accrued Liabilities 13.31K 8.95K $4.37K +48.82%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ATRIUM THERAPEUTICS, INC.
    • Ticker Symbol: RNA